FILKRI (filgrastim-laha) by Accord BioPharma Inc.,: new human prescription drug listing
FILKRI: new human prescription drug listing. Dated 113 days ago, it serves as a historical benchmark. Score 80/100. As of 2026-11-04, from U.S. FDA National Drug Code (NDC) Directory via openFDA.
Data as of · Compiled by Zalwin from U.S. FDA National Drug Code (NDC) Directory via openFDA
Free preview: all 13 published fields of this record are shown below. Locked: 499 related FdaNdcDirectoryPulse records and the 5-column CSV export.
| Field | Value |
|---|---|
| Product | FILKRI |
| Generic name | filgrastim-laha |
| NDC | 69448-009 |
| Labeler | Accord BioPharma Inc., |
| Product type | HUMAN PRESCRIPTION DRUG |
| Approval pathway | BLA |
| Application number | BLA761027 |
| Dosage form | INJECTION, SOLUTION |
| Route | INTRAVENOUS, SUBCUTANEOUS |
| Active ingredients | FILGRASTIM 480 ug/.8mL |
| Pharmacologic class | Leukocyte Growth Factor [EPC] |
| Marketing start | 2026-07-15 |
| Package configurations | 2 |
| Peer records CSV (500 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch FILKRI
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Free first: a 10-record sample of records
See the real columns before you buy. One confirmation email, nothing else unless you opt in.
Unlock FILKRI + 500 peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Product · Labeler · Pathway · Form · Listed · official source URL
- Source agency: U.S. FDA National Drug Code (NDC) Directory via openFDA
- Record date: 2026-07-15
- Data refreshed: 2026-11-04
- Refunds on request within 14 days
Top FdaNdcDirectoryPulse records (HUMAN PRESCRIPTION DRUG first): Cyclophosphamide by Amneal Pharmaceuticals LLC · Cyclophosphamide by Amneal Pharmaceuticals LLC · YESAFILI (aflibercept-jbvf) by Biocon Biologics Inc. · CIPROFLOXACIN OTIC (ciprofloxacin) by Alembic Pharmaceutical · WELTRUZA (olanzapine) by Teva Pharmaceuticals USA, Inc. · Browse all by state and category →
LIVE PUBLIC DATA Source: U.S. FDA National Drug Code (NDC) Directory via openFDA · Last refreshed: Wed, 04 Nov 2026 18:12:05 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: FILKRI and 1,345 HUMAN PRESCRIPTION DRUG peers
- HUMAN PRESCRIPTION DRUG FdaNdcDirectoryPulse records like this one: 1,345
- Timing: Low: older than 30 days
- Estimated pipeline if you contact every HUMAN PRESCRIPTION DRUG peer: $269,000 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
80 / 100 Launch Signal Score
- Prescription or biologic product.
- Brand or biologic launch.
- Injectable: hospital and 503B relevance.
- Class: Leukocyte Growth Factor [EPC].
What is the FdaNdcDirectoryPulse record for FILKRI?
FILKRI by Accord BioPharma Inc.,: new human prescription drug listing (BLA) starting 2026-07-15.
How does FILKRI compare to other FdaNdcDirectoryPulse records?
It is 113 days old; check the official source for later updates before acting. Its Launch Signal Score of 80/100 puts it among the stronger signals in this feed.
FILKRI vs. top 3 peers
| Organization | Location | Record date |
|---|---|---|
| FILKRI | HUMAN PRESCRIPTION DRUG | 2026-07-15 |
| YESAFILI | HUMAN PRESCRIPTION DRUG | 2026-11-03 |
| LEROCHOL | HUMAN PRESCRIPTION DRUG | 2026-11-01 |
| CAMCEVI ETM | HUMAN PRESCRIPTION DRUG | 2026-10-31 |
Related records
FdaNdcDirectoryPulse: Prescription (Rx) FdaNdcDirectoryPulse: Biologic (BLA)
How to monitor FILKRI and peer biologic (bla) records
Get new FdaNdcDirectoryPulse records like FILKRI by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new listings in your categories
FdaNdcDirectoryPulse emails new drug listings matching your pathway and product type.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.